Hereditary tumor screening

Product Introduction

Approximately 5% to 10% of the tumors are genetically inherited. Genetic testing is used to determine whether cancer patients or first-degree relatives carry genetic-related genes, assess their risk of developing cancer, develop early intervention programs, reduce cancer risk

Clinical significance

diagnosis of hereditary tumors

evaluation of prognosis of patients

to guide patients with physical examination and prevention

for the population

elatives of patients suffering from cancer

relatives of genetic tumor-related gene mutations in the individual

Detetion cycle

21 working days

Product recommendations

by the NCCN guide recommended all the cancer species~~
before the tumor can be found in advance of cancer~~
comprehensive coverage of a clear guide recommended and large research genes
for different cancer Species, select the optimal targeted gene detection.~~

Test items

Detection of hereditary tumors Test content Focus on the application of departments
hereditary testing of breast / ovarian cancer BRCA1, BRCA2, PTEN and other 19 gene sequencing tumor internal medicine tumor surgery, Department of breast surgery, gynecology, physical examination center
hereditary detection of thyroid cancer CDH1, BRCA1, BRCA2, TP53 gene sequencing, tumor internal medicine tumor surgery, gastrointestinal related departments, physical examination center
hereditary detection of gastric cancer APC, BMPR1A, CDH1 and other 29 gene sequencing endocrinology, Department of breast surgery, physical examination center
hereditary detection of melanoma CDKN2A, CDKN1C, CDK4 gene sequencing oncology, dermatology, physical examination center
hereditary detection of colorectal cancer APC, BMPR1A, MUTYH and other gene sequencing tumor internal medicine, tumor surgery, gastrointestinal related departments, physical examination center
hereditary detection of renal cell carcinoma VHL, FH, MET, FLCN, WT1 gene sequencing urology, oncology, oncology, physical examination center
pituitary tumor Sexual detection AIP gene multiple exon sequencing endocrinology, oncology, cancer surgery, physical examination center
hereditary detection of prostate cancer HOXB13, HPC, MSR1 and other gene sequencing urological tumor internal medicine, tumor surgery, physical examination center
retinoblastoma heredity testing RB1 gene multiple exon sequencing pediatric tumor related departments, physical examination center
genetic testing of family members of hereditary tumors The proband carries the test of the mutations of the harmful gene to detect the tumor-related departments, the physical examination center
  • Contact Us
  • Shanghai Biotecan Pharmaceuticals Co., Ltd.
  • Telephone：+86-21-50277725
  • Address：

    First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai, China

Copyright © 2015-2018 Shanghai Biotecan Pharmaceuticals Co., Ltd. All Rights Reserved 沪ICP备09055310号-1 沪公网安备 31011502003232号